EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction

Jeremy W Tomlinson iD

Diabetes, Obesity and Metabolism · 2024-04 · 26 (S2) · 13-24

DOI: 10.1111/dom.15480 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2024-02. Verfasst von Jeremy W Tomlinson. Beteiligte Einrichtung: Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, U…. Hauptthemen laut MEDLINE: Bardet-Biedl Syndrome, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Medical Research Council, Wellcome Trust, NIHR Oxford Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bardet‐Biedl syndrome (BBS) is a rare, monogenic, multisystem disorder characterized by retinal dystrophy, renal abnormalities, polydactyly, learning disabilities, as well as metabolic dysfunction, including obesity and an increased risk of type 2 diabetes. It is a primary ciliopathy, and causative mutations in more than 25 different genes have been described. Multiple cellular mechanisms contribute to the development of the metabolic phenotype associated with BBS, including hyperphagia as a consequence of altered hypothalamic appetite signalling as well as alterations in adipocyte biology promoting adipocyte proliferation and adipogenesis. Within this review, we describe in detail the metabolic phenotype associated with BBS and discuss the mechanisms that drive its evolution. In addition, we review current approaches to the metabolic management of patients with BBS, including the use of weight loss medications and bariatric surgery. Finally, we evaluate the potential of targeting hypothalamic appetite signalling to limit hyperphagia and induce clinically significant weight loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bardet-Biedl SyndromeDiabetes Mellitus, Type 2HumansKidneyHyperphagiaWeight Loss

Stichwörter der Autor:innen

antiobesity drugappetite controlobesity therapyweight control

Autor:innen und Institutionen

  • Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

ORCID-Profile: Jeremy W Tomlinson

Förderung

  • Medical Research Council
  • Wellcome Trust
  • NIHR Oxford Biomedical Research Centre

Zitieren

APA

Tomlinson, J. W. (2024). Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction. Diabetes, Obesity and Metabolism, 26(S2), 13-24. https://doi.org/10.1111/dom.15480

Vancouver

Tomlinson JW. Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction. Diabetes, Obesity and Metabolism. 2024;26(S2):13-24. doi:10.1111/dom.15480

BibTeX
@article{Tomlinson2024,
  author = {Tomlinson, Jeremy W},
  title = {Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {13--24},
  doi = {10.1111/dom.15480}
}
Kostenlos starten →